MDMAMDMA

Altered insula connectivity under MDMA

This within-subjects, double-blind, randomised, placebo-controlled study (n=25) investigated the effects of MDMA (100mg) on brain connectivity, and found that it decreased functional connectivity insula/salience network, which was also correlated with baseline trait anxiety and acute experiences of altered bodily sensations under MDMA.

Authors

  • Carhart-Harris, R. L.
  • Erritzoe, D.
  • Feilding, A.

Published

Neuropsychopharmacology
individual Study

Abstract

Introduction: Recent work with noninvasive human brain imaging has started to investigate the effects of 3,4-methylenedioxymethamphetamine (MDMA) on large-scale patterns of brain activity. MDMA, a potent monoamine-releaser with particularly pronounced serotonin-releasing properties, has unique subjective effects that include: marked positive mood, pleasant/unusual bodily sensations and pro-social, empathic feelings. However, the neurobiological basis for these effects is not properly understood, and the present analysis sought to address this knowledge gap.Methods: To do this, we administered MDMA-HCl (100 mg p.o.) and, separately, placebo (ascorbic acid) in a randomized, double-blind, repeated-measures design with twenty-five healthy volunteers undergoing fMRI scanning. We then employed a measure of global resting-state functional brain connectivity and follow-up seed-to-voxel analysis to the fMRI data we acquired.Results: There was decreased right insula/salience network functional connectivity under MDMA. Furthermore, these decreases in right insula/salience network connectivity correlated with baseline trait anxiety and acute experiences of altered bodily sensations under MDMA.Discussion: The present findings highlight insular disintegration (ie, compromised salience network membership) as a neurobiological signature of the MDMA experience, and relate this brain effect to trait anxiety and acutely altered bodily sensations-both of which are known to be associated with insular functioning.

Unlocked with Blossom Pro

Research Summary of 'Altered insula connectivity under MDMA'

Introduction

MDMA (3,4-methylenedioxymethamphetamine) is described as an entactogen with stimulant- and psychedelic-like properties, notable for pronounced serotonin release and subjective effects that include elevated mood, pro-social feelings and unusual bodily sensations. Previous neuroimaging work using PET, EEG and fMRI has reported MDMA-related decreases in regional cerebral blood flow and changes in connectivity in medial temporal and limbic structures; converging evidence has also implicated the insula in interoception and anxiety, and prior PET work reported insular blood-flow decreases after MDMA. However, earlier resting-state functional connectivity (RSFC) studies of MDMA have not specifically examined salience-network membership or insula-centred network integrity, partly because of methodological choices such as seed selection or independent component approaches that did not target the salience network directly. Walpola and colleagues therefore re-analysed an existing within-subjects, double-blind, placebo-controlled resting-state fMRI data set to test the hypothesis that MDMA acutely alters insula connectivity and salience-network integrity. The primary aim was to use a data‑driven voxelwise metric, the Intrinsic Connectivity Contrast (ICC), to identify regions with altered whole-brain connectivity under MDMA and then interrogate those regions with conventional seed-to-voxel and ROI-to-ROI analyses. The authors also examined whether MDMA-induced changes in insula connectivity related to baseline trait anxiety and reports of unusual bodily sensations as a proxy for altered interoception.

Methods

This analysis used pre-existing fMRI data collected in a within-subjects, double-blind, randomised, placebo-controlled design. Twenty-five healthy volunteers (seven female, mean age 34 ± 11 years) with at least one prior experience of MDMA participated; visits were separated by 7 days and the order of MDMA (100 mg, oral) and placebo was counterbalanced. Resting-state BOLD scans were acquired twice per visit but only the first resting-state scan (to avoid carry-over from intervening tasks) was analysed; scans were performed roughly 60 and 113 minutes post-capsule ingestion with peak subjective effects reported around 100 minutes. MRI data were acquired on a 3-T Siemens Tim Trio using standard anatomical and BOLD sequences (3 mm isotropic voxels for functional images, TR = 2000 ms, TE = 31 ms). Preprocessing in SPM12 and CONN included slice timing correction, realignment, spatial smoothing with a 6 mm FWHM Gaussian kernel and normalisation to MNI space. Motion artefacts were handled via scrubbing using ART (outlier time points included as dummy regressors during de-noising); white-matter and CSF noise components were removed using CompCor. A band-pass filter (0.008–0.09 Hz) was applied. The authors tested for between-condition differences in mean motion and scans scrubbed. The principal analytic approach was the Intrinsic Connectivity Contrast (ICC), a voxelwise metric that weights the strength of each voxel’s connections to every other voxel, providing a data‑driven map of global functional connectivity without predefined seeds. First-level voxel-to-voxel covariance matrices were computed for each participant and condition, and condition differences were assessed with paired t-tests at p < 0.001 uncorrected and a 5-voxel cluster threshold to generate candidate clusters for follow-up. Clusters from the ICC were then used as seeds in standard seed-to-voxel RSFC analyses (paired t-tests, height p < 0.001, cluster-size p < 0.05 FDR-corrected) to characterise altered connectivity patterns. The authors report that a right insula cluster (MNI +46 +04 +02) identified by the ICC was selected for subsequent analyses. To test whether observed effects reflected broader salience-network disruption rather than idiosyncrasies of the ICC-derived seed, the investigators conducted ROI-to-ROI analyses using 6 mm spheres at previously published coordinates for three canonical salience-hub regions: the dorsal anterior cingulate cortex (dACC) and bilateral anterior insula (AI). Multiple comparisons were controlled using FDR at p < 0.05. Finally, the relationship between MDMA-related changes in right-insula connectivity (MDMA minus placebo) and two subjective measures—baseline trait anxiety and self-reported unusual bodily sensations following the MDMA scan—was examined using correlations, with a Bonferroni-adjusted threshold of p < 0.025 (0.05/2) and FDR correction.

Results

The ICC contrast (MDMA > placebo) produced a distributed set of 36 clusters across the Harvard‑Oxford atlas. A right insula cluster at MNI +46 +04 +02 was chosen for follow-up analyses. Seed-to-voxel maps for the insula cluster under each condition resembled the canonical salience network. Comparing MDMA with placebo, seed-to-voxel analyses revealed significantly decreased connectivity between the right insula seed and clusters in the right anterior insula (+38 +12 +00), left anterior insula (+38 +14 +08) and dorsolateral prefrontal cortex (left middle frontal gyrus, +02 +26 +54) under MDMA. ROI-to-ROI analyses using independently defined salience-network hubs supported reduced salience connectivity in the MDMA condition. When seeding the dACC, connectivity was significantly decreased only with the left AI. Seeding the right AI showed decreased connectivity only with the left AI, whereas seeding the left AI revealed decreased connectivity with both the right AI and the dACC. Correlations related to subjective measures survived correction: greater baseline trait anxiety was associated with larger MDMA-related decreases in connectivity between the right insula and a dorsolateral prefrontal region (superior frontal gyrus, +02 +24 +54), with a reported Pearson R2 of 0.61. Self-reported ‘unusual bodily sensations’ following MDMA were associated with decreased connectivity between the right insula and two clusters: the right superior frontal gyrus (+02 +20 +62) and the anterior mid-cingulate cortex (+08 +26 +32), with a reported Pearson R2 of 0.53. Both correlations met the revised FDR-corrected threshold. Quality-control analyses found no significant between-condition differences in mean motion (p = 0.71) or mean number of scans scrubbed (p = 0.57). Additional regression analyses including frequency of prior MDMA use as a nuisance covariate indicated that between-subject differences in prior use did not account for the reported functional connectivity effects. The extracted text does not report exact p-values for the main connectivity contrasts beyond thresholds or formal effect sizes for those contrasts.

Discussion

Using a data-driven voxelwise approach, Walpola and colleagues report that acute MDMA administration reduced right insula-centred functional connectivity, consistent with decreased integrity of the salience network. Follow-up seed-to-voxel and ROI-to-ROI analyses converged on diminished coupling between the right insula and bilateral anterior insula as well as dorsolateral prefrontal regions, and these connectivity reductions correlated with individual differences in baseline trait anxiety and with self-reported unusual bodily sensations under MDMA. The authors position these findings relative to prior PET and fMRI results that noted insular blood-flow decreases or altered connectivity in anxiety-related networks, arguing that their ICC-based approach allowed identification of salience-network involvement that earlier RSFC studies missed due to methodological constraints. They suggest the pattern—attenuated insula/salience connectivity linked to trait anxiety and altered interoception—could represent a candidate neurobiological mechanism by which MDMA may modulate networks relevant to anxiety disorders and potentially support its adjunctive therapeutic effects (for example, in PTSD). The paper emphasises that MDMA is not broadly anxiolytic in the state sense and hypothesises that its acute action may preferentially alter neural substrates related to trait vulnerability rather than momentary state anxiety. Several mechanistic caveats are acknowledged. The authors note that MDMA’s effects are primarily serotonergic but that multiple neuromodulators likely influence salience-network function; they therefore recommend future pharmacological‑challenge imaging studies (for example, using dopaminergic and serotonergic antagonists) to parse contributions of different systems. They also reconcile apparent discrepancies with literature on dopaminergic modulation of salience connectivity by highlighting potential interactions across neurotransmitter systems and emerging evidence for epigenetic modulation of the serotonin transporter influencing insula responsivity. Key limitations are detailed. The ICC is exploratory and selection of a single cluster for seed-based follow-up involves subjective choices, although the authors argue their choice followed prior implementations and was corroborated by independent ROI analyses. Reliance on self-report measures for trait anxiety and bodily sensations is noted as a weakness; the authors recommend objective physiological and behavioural measures of interoception in future work. The reported correlations are subject to non-independence because cluster selection and correlation computations were not cross-validated; larger samples and independent replication are needed. Physiological variables such as heart rate or blood pressure were not recorded during scanning, so it cannot be excluded that peripheral physiological changes drove insula connectivity differences. Finally, blinding was ineffective: participants correctly identified condition in 90% of sessions and the research team in 96%, which the authors acknowledge as a common problem in psychoactive‑drug neuroimaging and a limitation for interpreting subjective measures. Overall, the investigators conclude that MDMA acutely reduces right insula/salience network connectivity and that this neural effect relates to trait anxiety and altered interoceptive experience, but they underline the need for replication, mechanistic pharmacological studies and objective measures before drawing firm clinical implications.

View full paper sections

CONCLUSION

The present study employed a network theory approach, the Intrinsic Connectivity Contrast (ICC), to elucidate the impact of MDMA on voxelwise functional brain connectivity. The ICC allows functional connectivity analysis to proceed without the need to first geometrically define a priori ROIs, thus extending the scope of previous efforts. We observed alterations in functional connectivity between the placebo and MDMA condition in many clusters overlapping with the Harvard-Oxford Atlas (Supplementary Information S1), notably including the right insular cortex (Figure). All further analyses used the insula cluster revealed by the ICC as a seed ROI because it was selected by a prior application of the ICC, decreased right insular connectivity was strikingly absent from previous fMRI analyses applied to this data set, and the insula plays a crucial role in both subjective feelings of the bodyand anxiety. When we examined the functional network membership of the right insula cluster using seed-to-voxel functional connectivity in both the MDMA and placebo condition (Figureand), we observed a network corresponding to the salience networkupon visual inspection. A contrast between conditions (MDMA4placebo) revealed decreased connectivity between the right insula seed ROI, the bilateral anterior insula and portions of the DLPFC (ie, the middle frontal gyrus). We confirmed that decreased salience network connectivity following MDMA administration was not specific to our choice of insula ROI, by conducting an ROI-to-ROI analysis with independent coordinates reported for three hubs of the salience network: the left AI, the right AI and the dACC. Of note is the decreased connectivity between the right AI seed and left AI, but not the right AI seed and dACC, even when the search space for differences in statistically significant correlations was reduced from the whole brain to only three salience network ROIs (Figure). This suggests that altered right insula connectivity under MDMA might be specific to certain hubs of the salience network, leaving other connections between hubs functionally uncompromised., have previously demonstrated increased connectivity in the salience network (dACC and dorsolateral prefrontal cortex) in association with pre-scan anxiety, interpreted as evidence of trait anxiety coded to some degree in the functional architecture of the salience network (2007). Furthermore, alterations in insular functional connectivity following MDMA administration have never been explored despite converging evidence implicating a functional network anchored in the insula in subjective feelings of the bodyand anxiety. As such, we endeavored to investigate how differences in right insula functional connectivity under MDMA (compared with placebo) might be related to individual differences in trait anxiety. Interestingly, we found that greater decreases in right insular connectivity within a dorsolateral prefrontal region-the superior frontal gyrus-in individuals who had greater trait anxiety. The cluster of deactivation that negatively correlated with levels of trait anxiety overlapped and extended anteriorly beyond the boundaries of the salience network we functionally defined. Although speculative, it is intriguing to consider whether the observed correlation between baseline trait anxiety and MDMA-induced decreases in salience network connectivityspecifically between the right insula and superior frontal gyrus-might reflect the action of MDMA on a putative functional network coding trait anxiety. This would suggest a candidate mechanism (ie, pharmacologically attenuated salience network connectivity) for the therapeutic role of MDMA in clinical syndromes with anxiety as a core component (eg, PTSD). In line with such a possibility, meta-analyses of the functional neuroimaging of anxiety have found heightened insula activation in PTSD, Social Anxiety Disorder and Specific Phobia compared with controls, and in PTSD compared with both trauma-naïve and traumaexposed controls. Increased salience network connectivity has also been documented in a host of anxiety disorders, notably including PTSD. Furthermore, propranolol-another pharmacological agent investigated as an adjunct for PTSD therapy-decreases connectivity within the salience network. Thus, it is worth considering whether action at the salience network might be an important component of the mechanism by which MDMA operates in MDMA-assisted psychotherapy for PTSD. It should be noted that MDMA is not considered generally anxiolytic, as it has been shown to increase self-reported state anxiety. Thus, the acute therapeutic effect of MDMA may specifically target neural substrates coding trait, rather than state, anxiety (ie, the salience network). Future studies should specifically investigate this possibility, examining variations in the relationship between altered neural connectivity under MDMA and state vs trait anxiety, both acutely and in the long term. Based on the unique phenomenology of MDMA, we hypothesized that unusual bodily sensations might be related to dysregulated interoceptive processingserved by a body awareness network anchored in the right anterior insula. Thus, we investigated the correlation between self-reports of unusual bodily sensations and MDMAinduced decreases in right insula-anchored salience network connectivity. Our results revealed decreased right insular connectivity with the right SFG and anterior mid-cingulate cortex (aMCC). While decreased connectivity with the right SFG was also associated with greater levels of trait anxiety, decreased connectivity with the aMCC, a region implicated in body awareness, was uniquely related to awareness of unusual bodily sensations. As interoceptive awareness has been found to mediate the relationship between trait anxiety and the intensity of unpleasant feelings, our results raise the possibility that MDMA might attenuate unpleasant feelings-and conversely produce its characteristic positive feelings-by decreasing the integrity of a neural network important for encoding trait anxiety and supporting interoceptive awareness. It has previously been demonstrated that inductions of sad mood increase functional connectivity between the right insula and cingulate cortex, and our result supports the possibility that MDMA disrupts the functional circuitry supporting certain negative affective states by compromising the interoceptive network that supports awareness of such feelings. Furthermore, there is a developing theoretical basisto suggest that compromised functional integrity of this network might simultaneously give rise to subjective beliefs of unusual bodily sensations typical of the MDMA experience. Converging evidence of the salience network's importance in schizophreniaand altered salience network connectivity following dopaminergic challenge (ie, connectivity is increased by L-dopa and decreased by haloperidol;may initially seem at odds with our demonstration that MDMA alters insula/salience network connectivity. Human research suggests that serotonin mediates the majority of physiological and psychosocial effects of MDMA, while the effect of dopaminergic (D2) blockade was primarily limited to attenuating euphoria. However, a complex interaction between neuromodulators is likely to mediate salience network functioning. Indeed, recent work has suggested that epigenetic modification (ie, increased methylation) of the serotonin transporter gene (SLC6A4) promoter region predicts heightened insula reactivityand salience network connectivity. This phenomenon also has relevance for clinical syndromes, such as PTSD, as SLC6A4 methylation has been linked to unresolved trauma. Thus, an emerging relationship between epigenetic modulation of the serotonin transporter gene, stress/anxiety-related clinical pathology, and the salience network suggests that we should look beyond the confines of the dopaminergic system when thinking about salience network functioning. Future neuroimaging studies incorporating an acute MDMA challenge plus pretreatment with selective dopaminergic (eg, haloperidol, D2) and/or serotonergic (eg, ketanserin, 5-HT2A) receptor antagonists would help to elucidate the respective contributions of these neuromodulatory systems on the behavior of specific brain networks in both healthy individuals and those with anxiety/ trauma-related disorders (eg, PTSD). Previous resting-state studies examining functional brain networks under MDMA have not implicated the insula, and studies that have demonstrated insula involvement have not directly examined functional networks. One reason for this could be that ventromedial prefrontal cortex, hippocampus and amygdala functional connectivity with the insula is not altered under MDMA, if functional coupling between these regions is even expected in the first place. Indeed, of these anatomical regions, only the dorsal portion of the amygdala is thought to belong to the salience network. Furthermore, we did not find altered insula connectivity with any of these regions under MDMA in the present study. Roseman et al, selected 10 independent components of interest corresponding to functional network labels from the BrainMap database (6 components from the analysis were determined to be non-neural noise), but none were identified as corresponding to the salience network (2014) and only inter-network connectivity was examined. The only significant inter-network alteration under MDMA did not involve the insula. Finally, Gamma et al used positron emission tomography, and although they found a constellation of activations and deactivations under MDMA that they infer reflects a functional network, no formal network analysis approach was applied. Therefore, none of these approaches were able to identify altered insulaanchored functional network connectivity under MDMA due to their respective methodological constraints. Thus, our study represents the first synthesis of these lines of research, demonstrating decreased insula/salience network functional connectivity under MDMA and linking this to baseline levels of trait anxiety and changes in interoception. In light of recent hypotheses suggesting an 'insular view of anxiety', further understanding of how MDMA affects the insula might be crucial to elucidating the neurobiological underpinnings of re-emerging interest in MDMA as a therapeutic adjunct to psychotherapy in the treatment of anxiety disorders including PTSD, see Amoroso and Workman, 2016 for a preliminary meta-analysis).

Study Details

  • Study Type
    individual
  • Population
    humans
  • Characteristics
    crossoverdouble blindrandomizedplacebo controlledbrain measures
  • Journal
  • Compounds

Your Library